LUNG vs BDX
Head-to-Head Stock Analysis & Investment Rating
Last Updated: Aug 22, 2026
LUNG
BDX
Investment Advisor Scores
BDX
AI Analyst Insights
Detailed Metrics Comparison
| Metric | LUNG | BDX | Winner |
|---|---|---|---|
|
Valuation
Lower P/E and PEG ratios suggest a stock may be undervalued relative to earnings and growth. Value investors prefer lower multiples. |
|||
| Forward P/E | 28.3286 | 14.1044 | BDX |
| PEG Ratio | 0 | 1.1074 | Tie |
|
Growth
Higher revenue and earnings growth rates indicate a company is expanding faster. Strong growth often justifies premium valuations. |
|||
| Revenue Growth | -4.6% | 5.4% | BDX |
| Earnings Growth | 0.0% | -31.4% | LUNG |
|
Quality & Profitability
Higher Tradestie Score and profit margins reveal how efficiently a company operates. Strong profitability indicates competitive advantages. |
|||
| Tradestie Score | 34.8/100 | 36.4/100 | BDX |
| Profit Margin | -55.0% | 4.2% | BDX |
|
Risk Profile
Lower Beta and Implied Volatility values indicate reduced market risk. Conservative investors favor stocks with less price volatility. |
|||
| Beta | 1.00 | 1.00 | Tie |
|
Sentiment
AI Recommendation reflects overall analyst and proprietary sentiment. Stronger recommendations signal higher conviction. |
|||
| AI Recommendation | EXTENDED | EXTENDED | Tie |
Relative Price Performance (Last 90 Days)
Current Technical Phase
LUNG
MarkupPrice above SMA50, rising 50-day trend (14.1% over 20 days), RSI 64
BDX
MarkupPrice above SMA50, rising 50-day trend (7.9% over 20 days), RSI 79
Fundamentals Snapshot
| Metric | LUNG | BDX |
|---|---|---|
| Market Cap | — | — |
| Forward P/E | -2.4 | 14.4 |
| Trailing P/E | — | 32.5 |
| Revenue (TTM) | — | — |
| Revenue Growth | 0.0% | 0.1% |
| Gross Margin | 0.8% | 0.5% |
| Operating Margin | -0.4% | 0.2% |
| EPS | -1.15 | 5.78 |
| Dividend Yield | — | 0.02% |